CD33, an immunomodulatory transmembrane sialic acid binding protein expressed on myeloid cells, was identified as one such genetic risk factor associated with Alzheimer’s disease. This evidence concerns the gene CD33 and early-onset autosomal dominant Alzheimer disease.